The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 11: Ibrutinib Resistance in WM
Session Chair: Richard Furman (USA)
What mutations are associated with resistance to BTK-inhibitors in WM? L. Xu (USA)
What are the mechanisms of resistance to ibrutinib in WM? G. Yang (USA)
Does BCL2 play a role in ibrutinib resistance? M. Davids (USA)
Keynote Lecture: Evolutional Landscape of Ibrutinib Resistance D. Landau (USA)
Keynote Lecture: Understanding and overcoming ibrutinib resistance in B-cell malignancies A. Wiestner (USA)